BLSM BlossomHill Therapeutics, Inc. - Common Stock
No fundamentals data yet for this ticker.
Company insiders 8 insiders · 0 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Vincent Paul Liptak | — | Aug. 10, 2026 C | 22,687 | 2 | 0 | $74,700 |
| Sundeep Agrawal | — | Aug. 10, 2026 C | 578,524 | 0 | 0 | $0 |
| Jingrong Jean Cui | — | Aug. 10, 2026 C | 124,779 | 0 | 0 | $0 |
| Yishan Li | — | Aug. 10, 2026 C | 124,779 | 0 | 0 | $0 |
| John P. Schmid | — | Aug. 10, 2026 P | 6,000 | 1 | 0 | $96,000 |
| GORDON CARL L | — | Aug. 10, 2026 C | 2,714,279 | 1 | 0 | $10,000,000 |
| Geoffrey Raymond Oxnard | — | Aug. 6, 2026 A | — | 0 | 0 | $0 |
| Jason A Keyes | — | Aug. 6, 2026 A | 700 | 1 | 0 | $11,200 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 2 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, OrbiMed Capital GP VIII LLC | Aug. 18, 2026 | 8.90% | Initial filing | — | SEC |
| Cormorant Global Healthcare Master Fund, LP, Cormorant Global Healthcare GP, LLC, Cormorant Private Healthcare Fund III, LP, Cormorant Private Healthcare GP III, LLC, Cormorant Private Healthcare Fund V, LP, Cormorant Private Healthcare GP V, LLC, Cormorant Private Healthcare Fund VI, LP, Cormorant Private Healthcare GP VI, LLC, Cormorant Asset Management, LP, Chen Bihua | Aug. 13, 2026 | 11.80% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.